Approval · Notice of Compliance 23460 · 2020
UCERIS: Notice of Compliance 23460
Issued April 15, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23460
- Date
- April 15, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UCERIS | 02498057 | Marketed |
Medicinal ingredients
- BUDESONIDE 2 MG per ACT